Results 1-8 of 8 for drugs segment:8861256
- Ceisteanna ó Cheannairí - Leaders' Questions (7 Mar 2024)
Pearse Doherty: The Tánaiste talks about frustration. I mentioned that there must always be balance and consideration. The approval of a new drug is supposed to take 180 days. The Tánaiste talked about people with rare diseases and cancer patients. We are at the bottom of the list in Europe for accessing these drugs. All through the term of this Government that has been the situation. Irish...
- Ceisteanna ó Cheannairí - Leaders' Questions (7 Mar 2024)
Pearse Doherty: However, throughout the term of the Government we have been the laggard in Europe in processing and approving drugs that can save lives for public patients.
- Ceisteanna ó Cheannairí - Leaders' Questions (7 Mar 2024)
Micheál Martin: In fact, €98 million of new money has been provided since this Government came in for new medicines. I refer to 148 new medicines in the past three years, as well as 39 new drugs or new uses of existing drugs with an orphan designation. By orphan, we mean drugs for rare diseases and they are termed orphan drugs because of that. We spend €3 billion a year on medicines. That...
- Ceisteanna ó Cheannairí - Leaders' Questions (7 Mar 2024)
Micheál Martin: In the last three years there have been about 61 new drugs or new uses of existing drugs for use in oncology alone for cancer patients. It is a very rapidly moving area, particularly in terms of immunotherapy drugs and so on. The funding has gone up exponentially over time. We need a system to evaluate this and make sure we get best value for money. In principle, I am disposed to getting...
- Ceisteanna ó Cheannairí - Leaders' Questions (7 Mar 2024)
Pearse Doherty: ...a dhéanamh. Caithfidh athrú teacht air seo. Tá staidéar déanta fá dtaobh de agus tá muid ar chúl san Eoraip ina thaobh. The IPHA is holding its annual conference today and it has highlighted the length of time it is taking the health service to approve the availability of new drugs. This has the potential to make real life-changing differences to...
- Ceisteanna ó Cheannairí - Leaders' Questions (7 Mar 2024)
Pearse Doherty: We are talking about life-changing drugs that can save the lives of people with rare diseases and cancer. There is great frustration. Will the Tánaiste ensure multiannual funding is allocated to provide a clear and predictable budget for the HSE to manage a continuous supply of new medicines? Will he also ensure the issue of staff capacity is addressed? It was pointed out to the...
- Ceisteanna ó Cheannairí - Leaders' Questions (7 Mar 2024)
Pearse Doherty: People in my constituency and that of the Tánaiste are waiting over two years for drugs to be approved. If people have private healthcare, however, they can get them straight away.
- Ceisteanna ó Cheannairí - Leaders' Questions (7 Mar 2024)
Micheál Martin: .... In the last three years, this has amounted to €98 million, with 148 new medicines approved. The total expenditure in that basket was about €327 million, to the end of 2023. We also made €30 million available this year for new drugs. There has been €20 million in new Government investment and the HSE has been requested to identify €10 million in...